Hypermarcas (OTCMKTS:HYPMY) Shares Shorted: Short Interest Down 62.4% in September

Hypermarcas (OTCMKTS:HYPMY) saw a large drop in short interest in September. As of September 15th, there was short interest totaling 2,343 shares, a drop of 62.4% from the August 31st total of 6,225 shares. Based on an average daily volume of 12,182 shares, the short-interest ratio is currently 0.2 days. Currently, 0.0% of the shares of the stock are sold short.

Hypermarcas Price Performance

Shares of OTCMKTS HYPMY traded up $0.01 during mid-day trading on Friday, reaching $4.65. The company had a trading volume of 2,608 shares, compared to its average volume of 8,066. The company has a 50-day moving average price of $4.28 and a two-hundred day moving average price of $4.31. The stock has a market cap of $3.27 billion, a PE ratio of 9.30 and a beta of 0.71. The company has a current ratio of 1.86, a quick ratio of 1.26 and a debt-to-equity ratio of 0.50. Hypermarcas has a 1-year low of $3.71 and a 1-year high of $5.50.

Hypermarcas (OTCMKTS:HYPMY) last announced its earnings results on Thursday, August 6th. The company reported $0.14 EPS for the quarter, beating the consensus estimate of $0.13 by $0.01. Hypermarcas had a return on equity of 12.68% and a net margin of 19.77%. On average, equities analysts anticipate that Hypermarcas will post 0.53 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group upgraded shares of Hypermarcas to a “strong-buy” rating in a report on Monday, July 20th. One analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Buy”.

About Hypermarcas

Hypermarcas SA was a Brazilian consumer health and pharmaceutical company that developed, manufactured and marketed branded products for healthcare, personal care and consumer markets. Its portfolio historically included over-the-counter medicines, prescription products, vitamins, toiletries, cosmetics and other household or personal-care brands.

The company expanded through acquisitions and operated primarily in Brazil, building a broad portfolio of locally recognized brands. In the mid-2010s, Hypermarcas began divesting its non-pharmaceutical businesses to concentrate on healthcare and medicines.